Loading...
XTAI
3164
Market cap44mUSD
Jul 09, Last price  
16.45TWD
1D
-0.60%
1Q
-7.58%
Jan 2017
-30.00%
IPO
5.31%
Name

GenMont Biotech Inc

Chart & Performance

D1W1MN
XTAI:3164 chart
P/E
24.74
P/S
3.53
EPS
0.67
Div Yield, %
4.86%
Shrs. gr., 5y
-3.76%
Rev. gr., 5y
4.29%
Revenues
401m
+4.11%
170,938,000253,147,000298,719,000352,848,000514,577,000286,214,000226,821,000308,937,000564,525,000534,719,000540,780,000380,654,000406,532,000346,244,000325,191,000427,929,000368,546,000318,015,000385,373,000401,229,000
Net income
57m
-0.09%
10,873,00057,407,00051,313,00086,234,000147,542,00038,159,00028,430,00030,891,000-386,158,000-98,028,000-235,938,00045,600,000158,019,00057,451,00060,884,000113,132,00056,978,00032,991,00057,251,00057,198,000
CFO
74m
-40.62%
100,617,000108,533,000200,034,00039,937,000-23,576,000100,371,000-61,996,000-5,010,00045,337,00077,559,00056,032,00074,515,000118,273,000111,658,000137,948,00034,599,000123,946,00073,597,000
Dividend
Mar 27, 20250.8 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Based in Taiwan, GenMont Biotech Incorporation is primarily engaged in the comprehensive process of developing, manufacturing, and marketing functional probiotic products. Beyond its core offerings, the company also provides specialized probiotic formulations. It extends its services to include original formula design and production for health-oriented food items, as well as supplying relevant manufacturing equipment. Additionally, GenMont Biotech actively collaborates on the research, production, and clinical evaluation of a variety of other products. The company was established in 2000 and has its headquarters situated in Tainan City, Taiwan.
URL
https://www.genmont.com.tw/
IPO date
Jun 12, 2003
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT